AR027681A1 - Composiciones de liberacion sostenida para administracion parenteral - Google Patents

Composiciones de liberacion sostenida para administracion parenteral

Info

Publication number
AR027681A1
AR027681A1 ARP010101275A ARP010101275A AR027681A1 AR 027681 A1 AR027681 A1 AR 027681A1 AR P010101275 A ARP010101275 A AR P010101275A AR P010101275 A ARP010101275 A AR P010101275A AR 027681 A1 AR027681 A1 AR 027681A1
Authority
AR
Argentina
Prior art keywords
sustained release
release compositions
parenteral administration
compositions
animals
Prior art date
Application number
ARP010101275A
Other languages
English (en)
Original Assignee
Wyeth Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth Corp filed Critical Wyeth Corp
Publication of AR027681A1 publication Critical patent/AR027681A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/10—Anthelmintics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/14—Ectoparasiticides, e.g. scabicides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)

Abstract

Composiciones de liberacion sostenida que comprenden un compuesto de macrolida, un tensioactivo, un co-valente y un solvente. Las composiciones deliberacion sostenida de esta invencion pueden ser administradas parenteralmente a animales, y son utiles para prevenir o tratar infeccion o infestacion endo-o ectoparasítica de helmintos, acáridos o artropodos en animales de sangre caliente por períodos prolongados.
ARP010101275A 2000-03-20 2001-03-19 Composiciones de liberacion sostenida para administracion parenteral AR027681A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US19069900P 2000-03-20 2000-03-20

Publications (1)

Publication Number Publication Date
AR027681A1 true AR027681A1 (es) 2003-04-09

Family

ID=22702398

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP010101275A AR027681A1 (es) 2000-03-20 2001-03-19 Composiciones de liberacion sostenida para administracion parenteral

Country Status (15)

Country Link
US (1) US6552002B2 (es)
EP (1) EP1136081B1 (es)
JP (1) JP4817515B2 (es)
AR (1) AR027681A1 (es)
AT (1) ATE286406T1 (es)
AU (1) AU781682B2 (es)
BR (1) BR0101090A (es)
CA (1) CA2341281C (es)
DE (1) DE60108189T2 (es)
DK (1) DK1136081T3 (es)
ES (1) ES2233566T3 (es)
MX (1) MXPA01002861A (es)
NZ (1) NZ510538A (es)
PT (1) PT1136081E (es)
SI (1) SI1136081T1 (es)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101785861B (zh) * 2001-10-19 2014-08-13 爱德士实验室公司 用于药理活性化合物的可控释放的可注射组合物
UY27412A1 (es) * 2002-08-12 2003-06-30 Carlson Internat Inc Un nuevo producto para el combate de garrapatas y el proceso para la prepaacinn.
US7906128B2 (en) * 2002-10-21 2011-03-15 Wyeth Llc Use of neuronal sodium channel antagonists for the control of ectoparasites in homeothermic animals
US7396819B2 (en) * 2003-08-08 2008-07-08 Virbac Corporation Anthelmintic formulations
WO2005094210A2 (en) * 2004-03-12 2005-10-13 The Hartz Mountain Corporation Multi-action anthelmintic formulations
GB0425919D0 (en) * 2004-11-25 2004-12-29 Prosidion Ltd Indole-2-carboxylic acid amides
CN102143920B (zh) 2008-09-09 2015-05-13 旭硝子株式会社 玻璃板的风冷强化装置及风冷强化方法
UY33282A (es) * 2010-03-25 2011-09-30 Novartis Ag Composiciones endoparasiticidas
KR101494594B1 (ko) 2011-08-30 2015-02-23 주식회사 종근당 약리학적 활성물질의 서방성 지질 초기제제 및 이를 포함하는 약제학적 조성물
WO2013137748A1 (en) 2012-03-13 2013-09-19 Bayer New Zealand Limited Long acting compositions
JP5717034B2 (ja) * 2012-08-27 2015-05-13 丸和バイオケミカル株式会社 マクロライド系化合物を含有する土壌線虫防除用薬剤
KR101586791B1 (ko) 2012-12-28 2016-01-19 주식회사 종근당 ＧｎＲＨ 유도체의 서방성 지질 초기제제 및 이를 포함하는 약제학적 조성물
AU2014223993B2 (en) 2013-02-28 2016-09-08 Mira Pharma Corporation Injectable long-acting local anesthetic semi-solid formulations and its compostions
US10220093B2 (en) 2013-02-28 2019-03-05 Mira Pharma Corporation Long-acting semi-solid lipid formulations
ITUB20153652A1 (it) 2015-09-16 2017-03-16 Fatro Spa Microsfere contenenti lattoni macrociclici antielminitici
GB2552952B (en) * 2016-08-12 2020-03-04 Norbrook Lab Ltd Moxidectin topical liquid formulations
US10561606B2 (en) 2017-12-06 2020-02-18 Mira Pharma Corporation Injectable long-acting local anesthetic semi-solid gel formulations
US11426418B2 (en) 2017-12-06 2022-08-30 Mira Pharma Corporation Injectable long-acting semi-solid gel formulations
JP2022533749A (ja) * 2019-05-24 2022-07-25 ピードモント アニマル ヘルス インコーポレイテッド 長時間作用型注射用製剤およびその使用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4389397A (en) * 1980-08-04 1983-06-21 Merck & Co., Inc. Solubilization of ivermectin in water
JPS57171919A (en) * 1981-04-17 1982-10-22 Nippon Kayaku Co Ltd Orally administering composition for veterinary purposes
EP0179583A1 (en) * 1984-10-04 1986-04-30 Merck & Co. Inc. A system for enhancing the water dissolution rate and solubility of poorly soluble drugs
WO1997011709A1 (en) 1995-09-25 1997-04-03 Ashmont Holdings Limited Anthelmintic macrocyclic lactone compositions
DE19613972A1 (de) * 1996-04-09 1997-10-16 Bayer Ag Injektionsformulierungen von Avermectinen und Milbemycinen auf Basis von Rizinusöl
DE69725745D1 (de) * 1996-06-05 2003-11-27 Ashmont Holdings Ltd Injizierbare zusammensetzungen
DE19638045A1 (de) 1996-09-18 1998-03-19 Bayer Ag Injektionsformulierungen von Avermectinen und Milbemycinen
CA2211949A1 (en) * 1997-07-21 1999-01-29 David Farley Johnson Nonaqueous compositions for parenteral administration

Also Published As

Publication number Publication date
BR0101090A (pt) 2001-11-06
DK1136081T3 (da) 2005-02-21
AU2641501A (en) 2001-09-27
CA2341281A1 (en) 2001-09-20
EP1136081B1 (en) 2005-01-05
PT1136081E (pt) 2005-03-31
NZ510538A (en) 2002-06-28
JP2001261558A (ja) 2001-09-26
US6552002B2 (en) 2003-04-22
SI1136081T1 (en) 2005-04-30
DE60108189T2 (de) 2005-06-02
CA2341281C (en) 2010-11-02
EP1136081A1 (en) 2001-09-26
MXPA01002861A (es) 2002-06-04
DE60108189D1 (de) 2005-02-10
ATE286406T1 (de) 2005-01-15
ES2233566T3 (es) 2005-06-16
US20020004486A1 (en) 2002-01-10
AU781682B2 (en) 2005-06-09
JP4817515B2 (ja) 2011-11-16

Similar Documents

Publication Publication Date Title
AR027681A1 (es) Composiciones de liberacion sostenida para administracion parenteral
AR033903A1 (es) Una composicion de insulina modificada quimicamente para la administracion pulmonar
GT199900140A (es) Derivados de quinolin-2-ona alquinilsustituidos utiles como agentes anticancerosos.
BR0211332B1 (pt) composiÇço poliolefÍnica, processo para a preparaÇço de dita composiÇço, bem como artigo compreendendo a mesma.
ATE376996T1 (de) Antibakterielle mittel
CR7898A (es) Agente repelente
ECSP077348A (es) Composiciones de amitraz
BR0107748A (pt) Composições antimicrobianas
NO20052787D0 (no) N-alkyl-4-metylenamino-3-hydroksy-2-pyridoner som antimikrobielle midler
AR034427A1 (es) Compuestos de malononitrilo,composicion pesticida que lo comprende, metodo de control de pestes con el mismo, y su uso como ingrediente activo de dicha composicion
CR7864A (es) Piridodiacinas como fungicidas de plantas
CY1107789T1 (el) Ανθελμινθικαι συνθεσεις περιεχουσαι συνδυασμους αβερμεκτινων ή μιλβεμυκινων μετα δις-αρυλο ενωσεων
UY28038A1 (es) Nuevas formulaciones de liberación propongada inyectables
NO20052788L (no) N-sulfonyl-4-metylenamino-3-hydroksy-2-pyridoner som antimikrobielle midler
DE60034377D1 (de) Flammhemmende, faserverstärkte polyamidzusammensetzung
SE0301100D0 (sv) Skadedjursrepellent
PT1197215E (pt) Composicoes antelminticas
PA8619601A1 (es) Derivados oxazol de tetraciclinas
ITMI20031714A1 (it) Formazioni ad azione antitumorale.
UY26964A1 (es) Derivados de eritromicina 6-0-sustituidos con mayor tolerancia gastrointestinal
BR9911353A (pt) Compostos benzazol e seu uso
AR019119A1 (es) Un metodo para inhibir el ataque fungico y composiciones para utilizar con dicho metodo
BR0210632A (pt) Tratamento de doença parasìtica
ATE386919T1 (de) Tarnnetz
BRPI0417106A (pt) granulos de pesticida com surfactante melhorado de soltura rápida

Legal Events

Date Code Title Description
FC Refusal